公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2017 | Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan | Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN ; Yeh, H.-I.; Chen, J.-W.; YEN-WEN WU ; CHAU-CHUNG WU ; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators | PLoS ONE | 17 | 17 | |
2022 | Management of metastatic renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy: A real-world retrospective study from Taiwan | Chung H.-J.; Chang Y.-H.; Huang Y.-H.; Lin T.-P.; Wei T.-C.; FANG-JU LIN ; HUAI-HSUAN HUANG ; Wang H.-C. | Journal of the Chinese Medical Association : JCMA | 4 | 3 | |
2014 | Measuring health-related quality of life in chronic obstructive pulmonary disease: Properties of the EQ-5D-5L and PROMIS-43 short form | FANG-JU LIN ; Pickard, A.S.; Krishnan, J.A.; Joo, M.J.; Au, D.H.; Carson, S.S.; Gillespie, S.; Henderson, A.G.; Lindenauer, P.K.; McBurnie, M.A.; Mularski, R.A.; Naureckas, E.T.; Vollmer, W.M.; Lee, T.A. | BMC Medical Research Methodology | 45 | 43 | |
2023 | Medication Adherence | FANG-JU LIN ; YEN-MING HUANG ; YUNN-FANG HO | DiPiro's Pharmacotherapy: A Pathophysiologic Approach. 12th ed. | | | |
2020 | Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan | TZUNG-DAU WANG ; Huang S.-T.; Wang C.-Y.; FANG-JU LIN ; Chen H.-M.; FEI-YUAN HSIAO | ESC Heart Failure | 8 | 8 | |
2021 | Nephrotoxicity of teicoplanin-based combination therapy: Focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams | CHIH-HSUN TAI ; Shao, Chi-Hao; CHI-CHUAN WANG ; FANG-JU LIN ; JANN-TAY WANG ; CHIEN-CHIH WU | Journal of Antimicrobial Chemotherapy | | | |
2018 | On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study | LI-TING HO ; FANG-JU LIN ; Tseng, Wei-Kung; Yin, Wei-Hsian; YEN-WEN WU ; Li, Yi-Heng; Yeh, Hung-I; Chen, Jaw-Wen; CHAU-CHUNG WU ; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators | Journal of the Formosan Medical Association = Taiwan yi zhi | 8 | 8 | |
2012 | Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse | Mollberg, N.M.; Steinert, G.; Aigner, M.; Hamm, A.; FANG-JU LIN ; Elbers, H.; Reissfelder, C.; Weitz, J.; Büchler, M.W.; Koch, M. | Cancer Biology and Therapy | 13 | 13 | |
2017 | Patient Experience-based Value Sets: Are They Stable? | Simon Pickard, A.; Hung, Y.-T.; FANG-JU LIN ; Lee, T.A. | Medical Care | 10 | 8 | |
2015 | Positive Outcomes of Varicose Vein Surgery: The Patient Perspective | Cheng, W.-H.; Patel, H.; Lee, W.-J.; FANG-JU LIN ; Pickard, A.S. | Patient | 3 | 3 | |
2022 | Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation | SHIN-YI LIN ; Chang, Yu-Chen; FANG-JU LIN ; SUNG-CHUN TANG ; Dong Y.-H.; CHI-CHUAN WANG | Journal of the American Heart Association | 8 | 8 | |
2021 | Prenatal antidepressant use and the implication of hypertensive disorders during pregnancy | Yang L.-Y.; FANG-JU LIN ; Katz A.J.; Wang I.-T.; Wu C.-H. | American Journal of Obstetrics and Gynecology | 3 | 2 | |
2023 | Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017 | Liao, Heng-Ching; FANG-JU LIN ; Hsu, Chien-Ning; SUSAN SHUR-FEN GAU ; CHI-CHUAN WANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2020 | Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment | Li, Yi-Heng; Tseng, Wei-Kung; Yin, Wei-Hsian; FANG-JU LIN ; YEN-WEN WU ; Hsieh, I-Chang; Lin, Tsung-Hsien; Sheu, Wayne Huey-Herng; Yeh, Hung-I; Chen, Jaw-Wen; CHAU-CHUNG WU ; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators | Scientific Reports | 5 | 4 | |
2022 | Prognostic Factors for Clinical Outcomes in Patients with Newly Diagnosed Advanced-stage Hodgkin Lymphoma: A Nationwide Retrospective Study | Jerry Teng, Chieh-Lin; Tan, Tran-Der; Pan, Yun-Yi; Lin, Yu-Wen; Lien, Pei-Wen; Chou, Hsin-Chun; Chen, Peng-Hsu; FANG-JU LIN | Cancer control : journal of the Moffitt Cancer Center | 1 | 0 | |
2018 | Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non–Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin | Hirsh, V.; Wan, Y.; FANG-JU LIN ; Margunato-Debay, S.; Ong, T.J.; Botteman, M.; Langer, C. | Clinical Lung Cancer | 1 | 2 | |
2017 | Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria | Hsu, Feng-Yi; FANG-JU LIN ; Ou, Huang-Tz; Huang, Shih-Hui; CHI-CHUAN WANG | Kidney and Blood Pressure Research | 32 | 32 | |
2021 | Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study | FANG-JU LIN ; CHI-CHUAN WANG ; Hsu, Chien-Ning; Yang, Chen-Yi; CHIH-YUAN WANG ; Ou, Huang-Tz | Cardiovascular diabetology | 7 | 7 | |
2017 | Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus | FANG-JU LIN ; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; CHAU-CHUNG WU | Scientific Reports | 36 | 32 | |
2020 | Response | FANG-JU LIN ; Chang, Ting-Yu; JUNG-YIEN CHIEN | Chest | 0 | 0 | |